Impact of a Hospital Physical Therapy Program on Chronic Obstructive Pulmonary Disease (COPD) Patients

March 18, 2011 updated by: Universidade Federal de Sao Carlos

Impact of a Hospital Physical Therapy Program on Exacerbated Chronic Obstructive Pulmonary Disease Patients: A Randomized Controlled Trial

The Chronic Obstructive Pulmonary Disease is a leading global cause of morbidity and mortality, so it's important to find actions that could improve quality of life and decrease the mortality. The objective of this study is to verify if a ground walking program applied to hospitalized exacerbated COPD patients has effects in quality of life, exercise capacity, airways obstruction, body composition, heart rate variability, quadriceps isometric force and in the "Body-mass index, Airway Obstruction, Dyspnea, Exercise Capacity index" (BODE index). An evaluators-blinded randomized controlled study will be conducted in "Hospital Escola Municipal de São Carlos" where forty patients will be recruited to participate. The volunteers will be randomized in two groups with twenty patients, the usual care group, that will receive only the usual care of the hospital; and the trained group that will receive the same care, but will also participate in a ground walking program associated with respiratory exercises. It will be evaluated, in the start and at the end of the program, the health related and general quality of life and the Barthel index. Daily, the patient will be submitted to the Six Minute Walk Test, to a body composition analysis, to a hand grip test and to a dyspnea assessment, and will be calculated its BODE index. All patients will be invited to a follow up in the 12th and 24th weeks after hospital discharge, when they would receive the same evaluation of the last day in the hospital. All the collected data will be expressed in means and standard deviations or medians and range when appropriated. It will be chosen appropriated tests to compare and correlate them.

Study Overview

Status

Unknown

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • São Paulo
      • São Carlos, São Paulo, Brazil, 13566-488
        • Recruiting
        • Hospital Escola Municipal "Dr Horácio Carlos Panepucci
        • Contact:
        • Principal Investigator:
          • Juliano Ferreira Arcuri, Especialist
        • Principal Investigator:
          • Adriana Sanches Garcia de Araujo, Masters
        • Principal Investigator:
          • Valéria Amorim Pires Di Lorenzo, PhD
        • Sub-Investigator:
          • Bruna Varanda Pessoa, Masters
        • Sub-Investigator:
          • Julia Gianjoppe dos Santos, Especialist
        • Sub-Investigator:
          • Audrey Borghi-Silva, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • COPD Patients (FEV1/FVC < 0,70; FEV1 > 30% and < 80%)
  • Hospitalized for exacerbation of COPD

Exclusion Criteria:

  • Conditions that could restrict walking

    • Skeletal-muscle and joint disturbs
    • Extreme Obesity (BMI > 35kg/m²)
  • Heart Failure (New York Heart Association class III and IV)
  • Uncontrolled infection (fever > 38ºC and leukocytosis > 10000 cels/dl)
  • Need of Invasive Mechanical Ventilation after the beginning of the program
  • Previous Diagnosis of:

    • Stroke
    • Epilepsy
  • Coagulation disorders (INR > 1,5 or platelets < 50.000/m³)
  • Psychiatric Disorders or severe agitation
  • Cardiac or respiratory instability
  • Oxygen therapy > 3L/min at rest
  • Respiratory Rate > 30 breaths/min at rest
  • Tachycardia and Bradycardia
  • Vasoactive Drugs need

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Trained Group
This group will receive the usual care of the hospital and a ground walking training program associated with respiratory exercises.
The patients will walk on a corridor, for 40min, once a day. The speed will be controlled through a metronome, that will be programed to a frequency of steps/min determinated as 80% of the mean frequency of steps performed in six minutes walk test of that day. The 40min will be divided in 3min of walk and 2min of rest, totalizing 24min of exercise and 16min of rest. Furthermore, these patients, in sitting position, will receive orientation to do calm and slow inspirations and expirations, associated with pursed lips expiration. They will try to maintain its Respiratory Rate in 6bpm, during four minutes.
Other Names:
  • Physical Therapy
  • Respiratory Rehabilitation
No Intervention: Usual Care Group
This group will only receive the usual care of the hospital, including physical therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Exercise Capacity
Time Frame: Daily, as soon as medically appropriated, during the hospitalization
It will be evaluated through the six minutes walking distance, performed according to ATS rules.
Daily, as soon as medically appropriated, during the hospitalization
Change in BODE index
Time Frame: Daily, as soon as medically appropriated, during the hospitalization
The Body-Mass Index, Airways Obstruction, Dyspnea, Exercise Capacity (BODE) index. This is a multidimensional evaluation that includes Forced Expiratory Volume in the first second, Body-Mass Index, 6 Minutes Walking Distance and mMRC score. It is an index to predict mortality.
Daily, as soon as medically appropriated, during the hospitalization

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Perceived Dyspnea
Time Frame: Daily, as soon as medically appropriated, during the hospitalization
Dyspnea during the six minutes walk test through the BORG CR10 scale
Daily, as soon as medically appropriated, during the hospitalization
Change in Perceived discomfort in lower limbs
Time Frame: Daily, as soon as medically appropriated, during the hospitalization
Evaluated during the six minutes walk test through the BORG CR10 scale
Daily, as soon as medically appropriated, during the hospitalization
Change in Variation in Heart Rate
Time Frame: Daily, as soon as medically appropriated, during the hospitalization
It will be evaluated the variation in the Heart Rate during the six minutes walk test (Exercise Peak - rest)
Daily, as soon as medically appropriated, during the hospitalization
Change in the need of oxygen therapy
Time Frame: Daily, as soon as medically appropriated, during the hospitalization
Will be evaluated the need of oxygen therapy during the six minutes walk test
Daily, as soon as medically appropriated, during the hospitalization
Change in Handgrip Isometric Force
Time Frame: Daily, as soon as medically appropriated, during the hospitalization
It will be evaluated through a hand grip dynamometer.
Daily, as soon as medically appropriated, during the hospitalization
Change in General Quality of Life
Time Frame: first day of the protocol and at the day of discharge
It will be evaluated through the SF-36 questionnaire
first day of the protocol and at the day of discharge
Change in Body Composition
Time Frame: Daily, as soon as medically appropriated, during the hospitalization
It will be performed through a body composition monitor, evaluating weight, body Fat percentage, Muscle Mass, Basal Metabolic Rate, Bone Mass and Total Body Water Percentage.
Daily, as soon as medically appropriated, during the hospitalization
Change in Forced Expiratory Volume in the First Second
Time Frame: Daily, as soon as medically appropriated, during the hospitalization
It will be evaluated through espirometry
Daily, as soon as medically appropriated, during the hospitalization
Days in hospital
Time Frame: At the discharge
At the discharge
Change in Reported Dyspnea
Time Frame: Daily, as soon as medically appropriated, during the hospitalization
It will be evaluated through the Modified Medical Research Concil Questionnaire
Daily, as soon as medically appropriated, during the hospitalization
Change in Heart Rate Variability
Time Frame: first day of the protocol and at the day of discharge
It will be recorded through a cardiac monitor, and analized in the time and frequency domain, and non-linear analysis.
first day of the protocol and at the day of discharge
Quadriceps Isometric Force
Time Frame: first day of the protocol and at the day of discharge
It will be evaluated through a hand held dynamometer.
first day of the protocol and at the day of discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Valéria Amorim Pires Di Lorenzo, PhD, Universidade Federal de Sao Carlos
  • Principal Investigator: Adriana Sanches Garcia de Araujo, Masters, Universidade Federal de Sao Carlos
  • Principal Investigator: Juliano Ferreira Arcuri, Especialist, Universidade Federal de Sao Carlos

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2011

Primary Completion (Anticipated)

August 1, 2012

Study Completion (Anticipated)

August 1, 2012

Study Registration Dates

First Submitted

February 11, 2011

First Submitted That Met QC Criteria

February 11, 2011

First Posted (Estimate)

February 14, 2011

Study Record Updates

Last Update Posted (Estimate)

March 21, 2011

Last Update Submitted That Met QC Criteria

March 18, 2011

Last Verified

February 1, 2011

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Obstructive Pulmonary Disease

Clinical Trials on Ground Walking Program

Subscribe